Y. Zhou

发表

IgA and IgG hypogammaglobulinemia in Waldenström’s macroglobulinemia

S. Treon, Z. Hunter, M. Morra, 2010, Haematologica.

Whole Genome Sequencing Reveals a Widely Expressed Mutation (MYD88 L265P) with Oncogenic Activity in Waldenstrom's Macroglobulinemia

D. Skifter, S. Lincoln, J. Laramie, 2011 .

A Somatic Variant in MYD88 (L265P) Revealed by Whole Genome Sequencing Differentiates Lymphoplasmacytic Lymphoma From Marginal Zone Lymphomas

N. Harris, G. Pinkus, S. Rodig, 2011 .

Vorinostat induced cellular stress disrupts the p38 mitogen activated protein kinase and extracellular signal regulated kinase pathways leading to apoptosis in Waldenström macroglobulinemia cells

N. Munshi, Hsiuyi Tseng, S. Treon, 2011, Leukemia & lymphoma.

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

N. Harris, D. Skifter, S. Lincoln, 2012, The New England journal of medicine.

The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.

S. Treon, Z. Hunter, Guang Yang, 2014, Blood.

small somatic deletions associated with B-cell lymphomagenesis characterized by highly recurring MYD 88 and WHIM-like CXCR 4 mutations , The genomic landscape of Waldenstöm ' s Macroglobulinemia

S. Treon, Z. Hunter, Guang Yang, 2013 .

Transcriptional repression of plasma cell differentiation is orchestrated by aberrant over‐expression of the ETS factor SPIB in Waldenström macroglobulinaemia

S. Treon, Z. Hunter, R. Carrasco, 2014, British journal of haematology.

MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.

N. Munshi, N. Lindeman, S. Treon, 2013, Blood.

MYD 88 L 265 P in Waldenström macroglobulinemia , immunoglobulin M monoclonal gammopathy , and other B-cell lymphoproliferative disorders using conventional and quantitative allele-speci fi c polymerase chain reaction

N. Munshi, N. Lindeman, S. Treon, 2013 .

polymerase chain reaction disorders using conventional and quantitative allele-specific monoclonal gammopathy, and other B-cell lymphoproliferative MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M

N. Munshi, N. Lindeman, S. Treon, 2013 .

polymerase chain reaction disorders using conventional and quantitative allele-specific monoclonal gammopathy , and other B-cell lymphoproliferative MYD 88 L 265 P in Waldenström macroglobulinemia , immunoglobulin

N. Munshi, N. Lindeman, S. Treon, 2013 .

Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.

Jian-jun Zhao, J. Cheng, N. Munshi, 2015, Cancer research.

Hepcidin is produced by lymphoplasmacytic cells and is associated with anemia in Waldenström's macroglobulinemia.

Hsiuyi Tseng, S. Rodig, S. Treon, 2011, Clinical lymphoma, myeloma & leukemia.

Detection Of MYD88 L265P In Peripheral Blood Of Patients With Waldenström's Macroglobulinemia and IgM Monoclonal Gammopathy Of Undetermined Significance

N. Lindeman, S. Treon, Z. Hunter, 2013 .

A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia.

N. Gray, S. Treon, Y. Tai, 2013, Blood.

Histone deacetylase inhibitors demonstrate significant preclinical activity as single agents, and in combination with bortezomib in Waldenström's macroglobulinemia.

N. Munshi, S. Treon, M. Fulciniti, 2011, Clinical lymphoma, myeloma & leukemia.

Soluble CD27 is a faithful marker of disease burden and is unaffected by the rituximab-induced IgM flare, as well as by plasmapheresis, in patients with Waldenström's macroglobulinemia.

Hsiuyi Tseng, S. Treon, E. Hatjiharissi, 2009, Clinical lymphoma & myeloma.

Matrix metalloproteinase-8 is overexpressed in Waldenström's macroglobulinemia cells, and specific inhibition of this metalloproteinase blocks release of soluble CD27.

Hsiuyi Tseng, S. Treon, Jingrui Jiang, 2011, Clinical lymphoma, myeloma & leukemia.

Waldenström macroglobulinemia lymphoplasmacytic cells by activation of Bruton tyrosine kinase in A mutation in MYD88 (L265P) supports the survival of

N. Gray, S. Treon, Z. Hunter, 2014 .

MYD88 L265P Promotes Survival of Waldenstrom's Macroglobulinemia Cells by Activation of Bruton's Tyrosine Kinase

S. Treon, Y. Tai, Z. Hunter, 2012 .